China National Accord Medicines Corporation Ltd. (000028.SZ)
CNY 29.96
(-0.5%)
CNY 29.96
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.17 Billion | 2.56 Billion | 1.65 Billion | 1.5 Billion | 2 Billion | 1.32 Billion |
| Net Income | 1.59 Billion | 1.77 Billion | 1.52 Billion | 1.72 Billion | 1.48 Billion | 1.34 Billion |
| Depreciation & Amortization | 1.58 Billion | 1.3 Billion | 1.26 Billion | 1.05 Billion | 791.62 Million | 116.25 Million |
| Deferred income taxes | -45.65 Million | -74.98 Million | -73.37 Million | -12.31 Million | 2.34 Million | 280.58 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -474.21 Million | -1.01 Billion | -1.31 Billion | -1.28 Billion | -278.48 Million | 24.03 Million |
| Other non-cash items | 4.15 Billion | 496.17 Million | 178.26 Million | 7.47 Million | 2.98 Million | -166.11 Million |
| Investing Cash Flow | -295.11 Million | -342.81 Million | -455.53 Million | -2.78 Billion | -240.44 Million | -222.45 Million |
| Investments in PPE | -322.2 Million | -322.19 Million | -370.43 Million | -293.82 Million | -245.16 Million | -255.48 Million |
| Acquisitions | 30.8 Million | -126.35 Million | -109.95 Million | -2.64 Billion | -97.01 Million | 2.46 Million |
| Investment purchases | -8.74 Million | -74.89 Million | -147.02 Million | -50.11 Million | -56 Million | -124.57 Million |
| Sales/Maturities of investments | 5.02 Million | 164.55 Million | 172.1 Million | 179.19 Million | 151.84 Million | 131.4 Million |
| Other Investing Activities | 1.00 | 16.06 Million | -234.52 Thousand | 27.61 Million | 5.89 Million | 23.72 Million |
| Financing Cash Flow | -2.4 Billion | -1.5 Billion | -1.87 Billion | -1.74 Billion | -969.16 Million | 2.85 Billion |
| Debt repayment | -486.53 Million | -1.53 Billion | -1 Billion | -427.34 Million | -99.84 Million | -79.67 Million |
| Dividends payments | -342.5 Million | -256.87 Million | -342.5 Million | -256.87 Million | -171.25 Million | -273.83 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -302.31 Million | 604 Million | -254.04 Million | -763.17 Million | -379.31 Million | 3.21 Billion |
| Accounts receivables | -3.99 Billion | 1.22 Billion | -2.12 Billion | -2.98 Billion | -793.3 Million | -1.66 Billion |
| Accounts payables | 3.68 Billion | -1.94 Billion | 2.13 Billion | 2.12 Billion | 1 Billion | 2.29 Billion |
| Inventory | -170.13 Million | -217.83 Million | -1.25 Billion | -406.38 Million | -524.15 Million | -608.95 Million |
| Other working capital | -79.9 Million | -74.98 Million | -73.37 Million | -12.31 Million | 29.23 Million | 632.98 Million |
| Cash at beginning of period | 6.01 Billion | 4.73 Billion | 5.4 Billion | 8.42 Billion | 7.63 Billion | 3.67 Billion |
| Cash at end of period | 6.5 Billion | 5.44 Billion | 4.73 Billion | 5.4 Billion | 8.42 Billion | 7.63 Billion |
| Capital Expenditure | -322.2 Million | -322.19 Million | -370.43 Million | -293.82 Million | -245.16 Million | -255.48 Million |
| Effect of forex changes on cash | -941.39 Thousand | -1.18 Million | 390.58 Thousand | -52.53 Thousand | -175.69 Thousand | -310.82 Thousand |
| Net cash flow / Change in cash | 485.99 Million | 708.66 Million | -671.6 Million | -3.02 Billion | 790.55 Million | 3.95 Billion |
| Free Cash Flow | 2.84 Billion | 2.23 Billion | 1.28 Billion | 1.2 Billion | 1.75 Billion | 1.06 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 322.05 Million | 354.71 Million | 388.77 Million | 1.59 Billion | 409.59 Million | 359.41 Million |
| Depreciation & Amortization | - | 433.04 Million | 433.04 Million | 1.58 Billion | 410.54 Million | -667.31 Million |
| Deferred income taxes | - | - | - | -45.65 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -474.21 Million | -4.24 Billion | 7.46 Billion |
| Other non-cash items | 191.84 Million | 1.65 Billion | -1.01 Billion | 4.15 Billion | 4.97 Billion | -7.17 Billion |
| Investing Cash Flow | 98.17 Million | -117.42 Million | -60.68 Million | -295.11 Million | -79.28 Million | 8.11 Million |
| Investments in PPE | -64.16 Million | -67.26 Million | -71.9 Million | -322.2 Million | -97.85 Million | -69.93 Million |
| Acquisitions | 505.84 Thousand | -69.24 Million | 86.31 Thousand | 30.8 Million | 21.97 Million | 2.66 Million |
| Investment purchases | -8.05 Million | -505 Thousand | -4.92 Million | -8.74 Million | -4.12 Million | -1.12 Million |
| Sales/Maturities of investments | 166.73 Million | 16.71 Million | 16.06 Million | 5.02 Million | 724.48 Thousand | 79.04 Million |
| Other Investing Activities | 3.65 Million | 4.88 Million | 19.91 Million | 1.00 | 26.91 Million | -2.52 Million |
| Financing Cash Flow | -939.43 Million | -1.16 Billion | 119.03 Million | -2.4 Billion | -384.94 Million | -604.97 Million |
| Debt repayment | -50.13 Million | -194.4 Million | -72.46 Million | -486.53 Million | -186.99 Million | -258.69 Million |
| Dividends payments | -65.94 Million | -424.02 Million | -59.51 Million | -342.5 Million | -342.5 Million | -80.11 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -823.35 Million | -530.06 Million | 46.57 Million | -302.31 Million | 1.99 Billion | -266.15 Million |
| Accounts receivables | - | - | - | -3.99 Billion | -3.99 Billion | 6.78 Billion |
| Accounts payables | - | - | - | 3.68 Billion | - | 360.51 Million |
| Inventory | - | - | - | -170.13 Million | -170.13 Million | 672.35 Million |
| Other working capital | - | - | - | -79.9 Million | -79.9 Million | -360.51 Million |
| Cash at beginning of period | 5.54 Billion | 5.26 Billion | 6.5 Billion | 6.01 Billion | 5.18 Billion | 5.44 Billion |
| Cash at end of period | 5.05 Billion | 5.54 Billion | 5.72 Billion | 6.5 Billion | 6.5 Billion | 4.82 Billion |
| Capital Expenditure | -64.16 Million | -67.26 Million | -71.9 Million | -322.2 Million | -97.85 Million | -69.93 Million |
| Effect of forex changes on cash | 24.06 Thousand | -1.22 Million | 2810.99 | -941.39 Thousand | 2527.30 | 12.67 Thousand |
| Net cash flow / Change in cash | -489.52 Million | 279.04 Million | -778.94 Million | 485.99 Million | 1.31 Billion | -617.64 Million |
| Free Cash Flow | 449.73 Million | 1.51 Billion | -697.35 Million | 2.84 Billion | 1.45 Billion | -90.74 Million |
FG
0H8T
STEM
GNFC
AOMFF
5714